Ibnsina Pharma (EGX:ISPH)

Market Cap	11.15B +29.7%
Revenue (ttm)	76.60B +37.2%
Net Income	771.11M +54.9%
EPS	0.76 +54.9%
Shares Out	1.01B
PE Ratio	14.46
Forward PE	7.23
Dividend	0.16 (1.45%)
Ex-Dividend Date	Apr 27, 2026

Volume	4,814,585
Average Volume	10,650,412
Open	11.08
Previous Close	11.08
Day's Range	11.03 - 11.16
52-Week Range	8.17 - 13.72
Beta	0.69
RSI	58.82
Earnings Date	May 20, 2026

About Ibnsina Pharma

Ibnsina Pharma operates as a pharmaceutical distributor in Egypt. The company offers pharmaceutical and cosmetics products to private and public-sector customers, including retail chains, independent pharmacies, wholesalers, hospitals, and healthcare institutions. It also provides warehousing and logistics services for its suppliers; marketing solutions; importation and packaging services; and market research and analysis services, as well as telesales and promotion services. The company was founded in 2001 and is headquartered in El Obour City...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2001
• Employees: 5,500
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: ISPH

Financial Performance

In 2025, Ibnsina Pharma's revenue was 76.60 billion, an increase of 37.17% compared to the previous year's 55.84 billion. Earnings were 771.11 million, an increase of 54.90%.